$ACIXF
From LinkedIn
Dr. George Chrysant and I sat down with KOKH FOX 25 News, Oklahoma to discuss new research from the American Heart Association, and the implications are far bigger than many realize.
By 2050, 6 in 10 U.S. women are projected to have some form of cardiovascular disease. At the same time, rates of diabetes and obesity in women are expected to rise by 67% and 36%, respectively. Even more concerning, cardiovascular disease is accelerating among younger populations, impacting nearly a third of women ages 20–44 and rising sharply among girls.
This isn’t just a women’s health issue. It’s a public health issue that affects families, communities, and the future of our healthcare system.
Despite being the leading cause of death for women, heart disease is still too often underdiagnosed, especially when symptoms don’t present in typical ways. That gap in awareness, detection, and access to care is something we must address now.
At Acarix, we believe earlier insight
$ACIXF From the CEO:
Great to spend time at #ACC with Ken Nelson, whose experience and perspective continue to be incredibly valuable as we scale Acarix in the U.S. and beyond.
What stands out most is the convergence we are seeing across the ecosystem. Conversations with customers, partners, and industry leaders are no longer siloed. Commercial strategy, R&D innovation, and collaborative partnerships are aligning in a very real way.
From a commercial standpoint, there is growing clarity around how #CADScor can be integrated into clinical workflows to drive better patient outcomes while reducing unnecessary testing. That alignment is critical as we continue to expand access and….
$ACIXF Article from 10th March 2026.
European Heart Journal.
See attached.
https://academic.oup.com/ehjimp/advance-article/doi/10.1093/ehjimp/qyag043/8512988
Article Navigation
JOURNAL ARTICLE ACCEPTED MANUSCRIPT
Diagnostic performance of combined biomarkers and phonocardiography versus the 2024 ESC risk factor-weighted clinical likelihood model for detecting coronary artery disease
$ACIXF Today Oct. 9th:
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACARIX AB
Qoute:
Proposed agenda
Opening of the general meeting and election of chairman of the general meeting
Preparation and approval of the voting list
Election of one or two persons to verify the minutes
Approval of the agenda
Determination as to whether the meeting has been duly convened
Resolution to change the terms in the Employee Stock Option Program 2025/2029
Closing of the general meeting.
Unqoute.
Nothing changes for us.
In short: "Resolution to change the terms in the Employee Stock Option Program 2025/2029"
, " Dilution
No change in dilution will arise as a result of the board's proposed amendments.".
$ACIXF Good News! When searching the swedish finansiel register the net short position of all outstanding short positions has dropped below the min. reporting limit. (This time the shorters lost money on their inventure, ( approx. 15%)).
$ACIXF The German reimbursement for medical devices with regards to Acarix CADScor will be settled when the 13 members of the Federal Joint Committee have their monthly sitdown on October 16th 11am to 3pm lt in Berlin, Germany.
Under TOP 8 , topic):
8.3.2 and 8.3.3 Guideline on Methods of Statutory Health Care:
Phonocardiography to rule out coronary heart disease
In order to decide on an amendment to the MVV-RL & KHMe-RL directive.
At this point I can’t find anything on the amount of reimbursement as there is some variables which the G-BA will uncover on 16th.
It is certain though that reimbursement depends on inclusion in specific service catalogues or as assistive devices listed in the Medical Aids Directory.
$ACIXF Notice.
We know the CEO increased his stock by 1 mill. to 10,904,824 shares and 50,000,000 stock options 10 days ago.
18th Sept.:
"Acarix Chairman Jan Poulsen Acquires Shares
I the period 15. -- 18. September, Jan Poulsen privately purchased 475,000 shares at an average price of SEK 0.3053.
Following this transaction, Jan Poulsen privately owns 1,647,815 shares and through 100% owned companies an additional 40,964,661 shares bringing his total holdings to 42,612,476 shares. His spouse has in the same period purchased 280,000 shares, and she now owns 427,006 shares".
$ACIXF As of today the future may well contain an emission of some kind.
Even if it happens we cannot avoid headlines like these when Large hospitals, V.A. etc. start ordering in Bulk.
Who knows if in 6 month from now we’ll have to adjust to news like this?
Goldman and Carnegie initiates investment in Acarix ab with a buy and price target of SEK 20 and 22.
Morning Herald: “Stocks with high potential”..Acarix…
UKFinancapulse.com: Millionaires buy this stock…
Disclaimer. I’m holding on to my shares.
$ACIXF
Our comment
As we have repeatedly emphasised, reimbursement remains a core pillar of the investment case. Monday’s press release, therefore, marks another significant step forward, with a second US payor agreeing to a fixed reimbursement of USD300 for the CADScor System. The first agreement was announced in mid-June 2025 with a regional Third-Party Administrator based in Oklahoma (link to our note).
Historically, private payors have tended to align on reimbursement levels and the adoption of fixed reimbursement structures. We therefore believe this development could mark the early stages of a domino effect, with additional private payors likely to follow.
The market reacted positively to the press release, with the share now trading around our base case of SEK0.40. We consider this move justified and would not be surprised if the market begins to price in a bull case scenario should positive news flow continue and revenue growth follow.”
They keep their estimates…
$ACIXF
Acarix receives reembursement from the second private payer.
https://lnkd.in/dbUG7hUj
Qoute:”Acarix CADScor was added at $300 in July to a high-performance provider network to enhance care and cost savings. This Payer provides a Network that services employers and individuals in the Oklahoma, Texas, Ohio, and Louisiana markets which consists of over 500,000 covered lives with 12,000+ Primary Care Physicians, 69.000+ Specialists and 3,000+ Facilities/Ancillaries”.
Unqoute.
